We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$54.4B
AUM Growth
+$4.48B
Cap. Flow
+$2.1B
Cap. Flow %
3.86%
Top 10 Hldgs %
19.38%
Holding
3,633
New
237
Increased
1,748
Reduced
1,306
Closed
214

Sector Composition

Rank Sector Weight
1 Technology 9.7%
2 Financials 9.06%
3 Healthcare 7.76%
4 Industrials 6.89%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASH icon
2651
Ashland
ASH
$3.5B
$400K ﹤0.01%
5,615
+258
+5% +$17.8K
BLD
2652
DELISTED
TopBuild
BLD
$399K ﹤0.01%
5,266
+701
+15% +$46.5K
IVOG icon
2653
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.7B
$399K ﹤0.01%
5,996
+176
+3% +$11.5K
PTY icon
2654
PIMCO Corporate & Income Opportunity Fund
PTY
$2.51B
$398K ﹤0.01%
24,163
+3,300
+16% +$54.9K
CIT
2655
DELISTED
CIT Group Inc.
CIT
$398K ﹤0.01%
8,087
+1,293
+19% +$62.7K
WLKP icon
2656
Westlake Chemical Partners
WLKP
$763M
$397K ﹤0.01%
15,913
+352
+2% +$7.96K
XHR
2657
Xenia Hotels & Resorts
XHR
$1.79B
$397K ﹤0.01%
18,405
+1,419
+8% +$30.9K
BTG icon
2658
B2Gold
BTG
$6.64B
$396K ﹤0.01%
127,801
-7,258
-5% -$19.6K
GNRC icon
2659
Generac Holdings
GNRC
$12.5B
$396K ﹤0.01%
7,994
-2,426
-23% -$121K
MGEE icon
2660
MGE Energy Inc
MGEE
$3.08B
$395K ﹤0.01%
+6,266
New +$408K
XLRN
2661
DELISTED
Acceleron Pharma
XLRN
$395K ﹤0.01%
9,314
+728
+8% +$27.3K
NTBL
2662
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$394K ﹤0.01%
1,585
+661
+72% +$154K
SHI
2663
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
$393K ﹤0.01%
6,891
+863
+14% +$51.3K
GNT
2664
GAMCO Natural Resources, Gold & Income Trust
GNT
$144M
$392K ﹤0.01%
58,428
-2,196
-4% -$15K
PVG
2665
DELISTED
PRETIUM RESOURCES INC.
PVG
$392K ﹤0.01%
34,334
-1,844
-5% -$20.1K
IMO icon
2666
Imperial Oil
IMO
$60.4B
$391K ﹤0.01%
12,533
+3,700
+42% +$115K
NYT icon
2667
New York Times
NYT
$10.2B
$390K ﹤0.01%
21,097
+581
+3% +$10.8K
PXLW icon
2668
Pixelworks
PXLW
$41.6M
$390K ﹤0.01%
5,133
-1,384
-21% -$93.8K
SITE icon
2669
SiteOne Landscape Supply
SITE
$4.53B
$390K ﹤0.01%
5,088
+404
+9% +$27.4K
JTD
2670
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
$390K ﹤0.01%
22,181
-26,769
-55% -$455K
COLL icon
2671
Collegium Pharmaceutical
COLL
$956M
$389K ﹤0.01%
+21,084
New +$302K
JGH icon
2672
Nuveen Global High Income Fund
JGH
$356M
$389K ﹤0.01%
22,986
-16,021
-41% -$271K
PBR icon
2673
Petrobras
PBR
$116B
$388K ﹤0.01%
37,659
-3,429
-8% -$35.1K
PGZ
2674
Principal Real Estate Income Fund
PGZ
$68.7M
$388K ﹤0.01%
22,600
+500
+2% +$8.67K
ATHN
2675
DELISTED
Athenahealth, Inc.
ATHN
$388K ﹤0.01%
2,916
+101
+4% +$12.9K

Similar funds

Raymond James & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Raymond James & Associates held 3,633 positions worth $54.4B, up 9% from $49.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Raymond James & Associates deployed $2.1B of net new capital in Q4 2017, opening 237 new positions and adding to 1,748 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $124M trimmed.

  • Raymond James & Associates's largest Q4 2017 buy was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.
  • Raymond James & Associates added most to iShares MSCI USA Min Vol Factor ETF in Q4 2017, an estimated $516M increase.
  • Raymond James & Associates's biggest Q4 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $124M.
  • Raymond James & Associates fully exited ABM Industries in Q4 2017, selling an estimated $3.17M.
  • Raymond James & Associates's ten largest holdings make up 19% of its $54.4B portfolio in Q4 2017.
  • Raymond James & Associates opened 237 new positions and closed 214 in Q4 2017.
  • Raymond James & Associates's portfolio value rose 9% quarter-over-quarter to $54.4B.

Based on Raymond James & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.